查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1876452

全球乾眼症治療設備市場 - 行業分析、規模、佔有率、成長、趨勢和預測（2025-2032 年） - 依類型、病因、應用、最終用戶和地區劃分

Dry Eye Disease Treatment Devices Market - Global Dry Eye Disease Treatment Devices Industry Analysis, Size, Share, Growth, Trends, and Forecast 2025-2032 - (By Type, By Cause, By Application,By End Users, By Geographic Coverage and By Company)
出版日期: | 出版商: Fairfield Market Research | 英文 193 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

隨著乾眼症負擔在各個年齡層和地區持續加重，全球乾眼症治療設備市場呈現強勁成長動能。螢幕依賴性的增加、生活方式的改變以及人們對眼部健康的日益重視，正在迅速推動對先進治療技術的需求。預計到 2025 年，該市場規模將達到 2.6 億美元，到 2032 年將達到 4.3 億美元，複合年增長率 (CAGR) 為 7.5%。從傳統治療方法轉向基於設備的治療，正在增強該行業的長期成長前景。

市場洞察

乾眼症 (DED) 已成為全球最常見的眼科疾病之一，嚴重影響患者的生活品質和視覺功能。隨著臨床醫生尋求更有效的治療方法，基於設備的療法因其非侵入性、快速緩解症狀以及能夠解決潛在的腺體功能障礙（而不僅僅是治療症狀）而備受關注。

熱脈衝療法、標靶光療、自動化瞼板腺治療和家用維護設備等技術進步不斷重塑治療體系。日益增強的公眾意識宣傳活動以及患者對高端治療方案日益增長的需求，進一步推動了市場成長。製造商正致力於人體工學設計、便攜性和提高治療效率，以滿足不斷增長的臨床和家庭需求。

市場推動因素

數位裝置使用量的快速成長，尤其是在年輕一代中，是導致乾眼症病例增加的主要因素之一。以電腦為中心的工作場所的興起、智慧型手機依賴性的增強以及長時間的螢幕暴露，都會導致眨眼異常和淚膜不穩定。年齡增長、環境因素、配戴隱形眼鏡、術後乾眼、藥物相關症狀等因素共同作用，導致疾病的盛行率持續上升。

創新技術是主要推動力，現代醫療器材能夠針對瞼板腺阻塞和淚液引流通道提供標靶治療。診斷能力的提升使得早期發現和治療機會更加廣泛。醫療保健成本的上漲、患者意識的增強以及臨床對整合技術解決方案日益增長的偏好，都支撐著持續的需求。監管審批的便利性和產品的廣泛普及也促進了市場擴張。

商機

全球市場在臨床和居家照護方面都蘊藏著巨大的商機。尤其是在已開發市場，患者越來越追求長期舒適，同時盡可能減少就診次數，這使得便於日常維護的緊湊型、易於使用的設備越來越受歡迎。專注於研發結合熱療、振動和機械刺激的成本效益型混合治療系統的公司預計將吸引大量關注。

遠端驗光、人工智慧驅動的眼科診斷以及與智慧監測平台的整合，為未來的成長提供了強勁的潛力。製造商與大型眼科診所連鎖機構之間的合作，提高了分銷效率，並提升了品牌知名度。此外，隨著醫療保健可近性的提高，新興市場的滲透率不斷擴大，眼科設備的普及應用也因此成為一條充滿希望​​的成長路徑。

區域分析

北美在全球乾眼症治療設備市場中佔主要佔有率，這主要得益於人們對乾眼症的廣泛認知、先進治療設備的高普及率以及日益嚴重的數碼眼疲勞。該地區擁有強大的眼科診所網絡、強大的購買力以及持續的技術創新。

歐洲市場持續穩定成長，這主要得益於人口老化、專業醫療服務覆蓋範圍的擴大以及對非侵入性治療日益增長的偏好。監管機構對先進醫療器材的支援以及對高品質眼科技術的強勁需求，都促進了該地區市場的擴張。

預計亞太地區將在預測期內成為成長最快的區域市場。快速的城市化、長時間的螢幕使用以及隱形眼鏡的高使用率是乾眼症盛行率上升的關鍵因素。中國、印度、日本和韓國等國家正在迅速擴大其眼科醫療基礎設施，這為設備製造商創造了巨大的機會。

拉丁美洲和中東/非洲地區由於醫療保健服務的改善、私立醫院網絡的擴張以及人們對眼健康和預防性護理技術的日益重視，展現出不斷增長的增長潛力。

主要公司

  • 愛爾康視覺有限公司 (Alcon Vision LLC)
  • 強生服務公司 (Johnson and Johnson Services Inc)
  • 艾伯維公司 (AbbVie Inc.)
  • Lumenis Be Ltd
  • ESW - Vision
  • MiBo Medical Group
  • Sight Sciences
  • Eyedetec Medical Inc.
  • BlephEx
  • NuSight Medicals- NuLids LLC
  • 其他

全球乾眼治療設備市場區隔

依類型

  • 瞼板腺疏通裝置
  • 淚小點阻塞裝置
  • 止痛裝置
  • 其他

依病因

  • 特發性
  • 罕見疾病
  • 手術
  • 藥物相關
  • 數位暴露
  • 衰老

依應用領域

  • 水分缺乏
  • 蒸發性

依最終使用者

  • 醫院
  • 眼科中心
  • 門診手術中心
  • 其他

依地區

  • 北美
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東和非洲

目錄

第一章 摘要整理

第二章：市場概覽

  • 市場定義與市場區隔
  • 市場動態
  • 價值鏈分析
  • 新冠疫情影響分析
  • 波特五力分析
  • 俄烏衝突的影響
  • PESTLE 分析
  • 監理分析
  • 價格趨勢分析

第三章 全球乾眼症治療設備市場展望，2019-2032

  • 全球乾眼症治療設備市場展望，依類型和價值（百萬美元），2019-2032
    • 瞼板腺疏通設備
    • 點狀阻塞設備
    • 止痛設備
    • 其他
  • 全球乾眼症治療設備市場展望，依病因和價值（百萬美元）， 2019-2032
    • 特發性
    • 罕見疾病
    • 手術
    • 藥物相關
    • 數位暴露
    • 年齡相關
  • 全球乾眼治療設備市場展望（依應用領域劃分，收入（百萬美元）），2019-2032
    • 水分不足
    • 汽化性
  • 乾眼治療設備市場展望（以最終用戶劃分，收入（百萬美元）），2019-2032
    • 醫院
    • 眼科中心
    • 門診手術中心
    • 其他
  • 全球乾眼治療設備市場展望（依地區劃分，收入（百萬美元）），2019-2032
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第四章：北美乾眼症設備市場展望（2019-2032）

第五章：歐洲乾眼症設備市場展望（2019-2032）

第六章：亞太地區乾眼症設備市場展望（2019-2032）

第七章：拉丁美洲乾眼症設備市場展望（2019-2032）

第八章：中東與非洲乾眼症設備市場展望（2019-2032）

第九章：競爭格局

  • 公司與區隔市場熱力圖
  • 公司市佔率分析（2024）
  • 競爭對手儀錶板
  • 公司簡介
    • 愛爾康視覺有限公司
    • 強生服務公司
    • 艾伯維公司
    • Lumenis Be Ltd
    • ESW - Vision
    • MiBo Medical Group
    • Sight Sciences
    • Eyedetec Medical Inc.
    • BlephEx
    • NuSight Medicals- NuLids LLC

第十章附錄

簡介目錄

The global Dry Eye Disease Treatment Devices Market is witnessing robust growth as the burden of dry eye continues to rise across age groups and geographies. With increasing screen dependency, lifestyle transitions, and expanding awareness of ocular health, demand for advanced treatment technologies is accelerating rapidly. The market is valued at USD 260 million in 2025 and is projected to reach USD 430 million by 2032, registering a CAGR of 7.5%. The shift from traditional treatment approaches to device-based therapeutic care is strengthening the industry's long-term growth outlook.

Market Insights

Dry Eye Disease (DED) has evolved into one of the most commonly diagnosed ophthalmic conditions globally, impacting quality of life and visual performance. As clinicians seek more effective interventions, device-based therapies are gaining momentum due to their non-invasive nature, faster relief outcomes, and ability to address underlying gland dysfunction rather than only providing symptomatic improvement.

Technological advancements such as thermal pulsation, targeted light-based therapy, automated meibomian gland treatment, and at-home maintenance devices continue to reshape the care continuum. Increasing awareness campaigns and growing willingness among patients to adopt premium therapeutic solutions are further supporting market expansion. Manufacturers are increasingly focusing on ergonomic design, portability, and improved treatment efficiency to meet rising clinical and at-home demand.

Market Drivers

A surge in digital device usage, particularly among younger populations, has become one of the most significant contributors to the growing incidence of dry eye. The rise in computer-centric work environments, increased smartphone dependence, and prolonged screen exposure contribute to blinking abnormalities and tear film instability. Combined with age-related changes, environmental factors, contact lens use, post-operative dryness, and medication-associated symptoms, the prevalence of the disease continues to escalate.

Innovation serves as a central driver, with modern devices offering targeted therapeutic action on meibomian gland obstructions and tear drainage pathways. Improved diagnostic capabilities are enabling early detection, thus expanding treatment opportunities. Growing healthcare expenditure, rising patient awareness, and greater clinical preference for integrated technology-based solutions support sustained demand. Favorable regulatory approvals and broader product availability further contribute to market expansion.

Business Opportunity

The global market offers considerable opportunities across both clinical and home-care settings. Compact and user-friendly devices designed for daily maintenance are becoming increasingly popular, especially in developed markets where patients prefer long-term comfort solutions with minimal clinic visits. Companies focusing on cost-effective, hybrid therapy systems that combine heat, vibration, and mechanical stimulation are expected to gain substantial traction.

Integration with tele-ophthalmology, AI-driven eye diagnostics, and smart-monitoring platforms presents strong potential for future growth. Partnerships between manufacturers and large eye care chains are improving distribution efficiency and helping companies enhance brand visibility. Additionally, expanding penetration into emerging markets, where rising healthcare access is boosting ophthalmic device adoption, offers promising growth avenues.

Region Analysis

North America holds a major share in the global Dry Eye Disease Treatment Devices Market due to widespread awareness of dry eye conditions, high adoption of advanced therapeutic devices, and increased prevalence of digital eye strain. The region benefits from a strong network of eye care clinics, high purchasing power, and ongoing technological innovation.

Europe continues to show steady growth driven by a rising elderly population, increased access to specialty care, and rising preference for non-invasive therapeutic options. Regulatory support for advanced medical devices and strong demand for premium eye care technologies contribute to the region's expanding market presence.

Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period. Rapid urbanization, extensive screen exposure, and high rates of contact lens use are major contributors to rising dry eye prevalence. Countries such as China, India, Japan, and South Korea are witnessing rapid expansion in eye care infrastructure, creating significant opportunities for device manufacturers.

Latin America and the Middle East & Africa show growing potential supported by improving healthcare access, expanding private hospital networks, and increasing awareness about eye health and preventive care technologies.

Key Players

  • Alcon Vision LLC
  • Johnson and Johnson Services Inc
  • AbbVie Inc.
  • Lumenis Be Ltd
  • ESW - Vision
  • MiBo Medical Group
  • Sight Sciences
  • Eyedetec Medical Inc.
  • BlephEx
  • NuSight Medicals- NuLids LLC
  • Others

Global Dry Eye Disease Treatment Devices Market Segmentation

By Type

  • Meibomian Gland Unclogging Devices
  • Punctual Occlusion Devices
  • Pain-Reliving Devices
  • Others

By Cause

  • Idiopathic
  • Rare Diseases
  • Surgery
  • Drug Intake Associated
  • Digital Exposure
  • Age-Related

By Application

  • Aqueous Deficient
  • Evaporative

By End Users

  • Hospitals
  • Eye Care Centers
  • Ambulatory Surgical Centers
  • Others

By Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Dry Eye Disease Treatment Devices Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value, 2025
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Porter's Fiver Forces Analysis
  • 2.6. Impact of Russia-Ukraine Conflict
  • 2.7. PESTLE Analysis
  • 2.8. Regulatory Analysis
  • 2.9. Price Trend Analysis
    • 2.9.1. Current Prices and Future Projections, 2025-2032
    • 2.9.2. Price Impact Factors

3. Global Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 3.1. Global Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 3.1.1. Meibomian Gland Unclogging Devices
    • 3.1.2. Punctual Occlusion Devices
    • 3.1.3. Pain-Reliving Devices
    • 3.1.4. Others
  • 3.2. Global Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 3.2.1. Idiopathic
    • 3.2.2. Rare Diseases
    • 3.2.3. Surgery
    • 3.2.4. Drug Intake Associated
    • 3.2.5. Digital Exposure
    • 3.2.6. Age-Related
  • 3.3. Global Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 3.3.1. Aqueous Deficient
    • 3.3.2. Evaporative
  • 3.4. Global Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 3.4.1. Hospitals
    • 3.4.2. Eye Care Centers
    • 3.4.3. Ambulatory Surgical Centers
    • 3.4.4. Others
  • 3.5. Global Dry Eye Disease Treatment Devices Market Outlook, by Region, Value (US$ Mn), 2019-2032
    • 3.5.1. North America
    • 3.5.2. Europe
    • 3.5.3. Asia Pacific
    • 3.5.4. Latin America
    • 3.5.5. Middle East & Africa

4. North America Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 4.1. North America Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 4.1.1. Meibomian Gland Unclogging Devices
    • 4.1.2. Punctual Occlusion Devices
    • 4.1.3. Pain-Reliving Devices
    • 4.1.4. Others
  • 4.2. North America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 4.2.1. Idiopathic
    • 4.2.2. Rare Diseases
    • 4.2.3. Surgery
    • 4.2.4. Drug Intake Associated
    • 4.2.5. Digital Exposure
    • 4.2.6. Age-Related
  • 4.3. North America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 4.3.1. Aqueous Deficient
    • 4.3.2. Evaporative
  • 4.4. North America Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 4.4.1. Hospitals
    • 4.4.2. Eye Care Centers
    • 4.4.3. Ambulatory Surgical Centers
    • 4.4.4. Others
  • 4.5. North America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
    • 4.5.1. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 4.5.2. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 4.5.3. U.S. Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 4.5.4. U.S. Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 4.5.5. Canada Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 4.5.6. Canada Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 4.5.7. Canada Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 4.5.8. Canada Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
  • 4.6. BPS Analysis/Market Attractiveness Analysis

5. Europe Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 5.1. Europe Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 5.1.1. Meibomian Gland Unclogging Devices
    • 5.1.2. Punctual Occlusion Devices
    • 5.1.3. Pain-Reliving Devices
    • 5.1.4. Others
  • 5.2. Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 5.2.1. Idiopathic
    • 5.2.2. Rare Diseases
    • 5.2.3. Surgery
    • 5.2.4. Drug Intake Associated
    • 5.2.5. Digital Exposure
    • 5.2.6. Age-Related
  • 5.3. Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 5.3.1. Aqueous Deficient
    • 5.3.2. Evaporative
  • 5.4. Europe Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 5.4.1. Hospitals
    • 5.4.2. Eye Care Centers
    • 5.4.3. Ambulatory Surgical Centers
    • 5.4.4. Others
  • 5.5. Europe Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
    • 5.5.1. Germany Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.2. Germany Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.3. Germany Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.4. Germany Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.5. Italy Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.6. Italy Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.7. Italy Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.8. Italy Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.9. France Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.10. France Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.11. France Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.12. France Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.13. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.14. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.15. U.K. Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.16. U.K. Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.17. Spain Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.18. Spain Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.19. Spain Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.20. Spain Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.21. Russia Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.22. Russia Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.23. Russia Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.24. Russia Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 5.5.25. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 5.5.26. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 5.5.27. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 5.5.28. Rest of Europe Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
  • 5.6. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 6.1. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 6.1.1. Meibomian Gland Unclogging Devices
    • 6.1.2. Punctual Occlusion Devices
    • 6.1.3. Pain-Reliving Devices
    • 6.1.4. Others
  • 6.2. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 6.2.1. Idiopathic
    • 6.2.2. Rare Diseases
    • 6.2.3. Surgery
    • 6.2.4. Drug Intake Associated
    • 6.2.5. Digital Exposure
    • 6.2.6. Age-Related
  • 6.3. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 6.3.1. Aqueous Deficient
    • 6.3.2. Evaporative
  • 6.4. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 6.4.1. Hospitals
    • 6.4.2. Eye Care Centers
    • 6.4.3. Ambulatory Surgical Centers
    • 6.4.4. Others
  • 6.5. Asia Pacific Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
    • 6.5.1. China Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.2. China Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.3. China Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.4. China Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 6.5.5. Japan Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.6. Japan Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.7. Japan Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.8. Japan Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 6.5.9. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.10. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.11. South Korea Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.12. South Korea Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 6.5.13. India Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.14. India Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.15. India Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.16. India Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 6.5.17. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.18. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.19. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.20. Southeast Asia Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 6.5.21. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 6.5.22. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 6.5.23. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 6.5.24. Rest of SAO Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
  • 6.6. BPS Analysis/Market Attractiveness Analysis

7. Latin America Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 7.1. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 7.1.1. Meibomian Gland Unclogging Devices
    • 7.1.2. Punctual Occlusion Devices
    • 7.1.3. Pain-Reliving Devices
    • 7.1.4. Others
  • 7.2. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 7.2.1. Idiopathic
    • 7.2.2. Rare Diseases
    • 7.2.3. Surgery
    • 7.2.4. Drug Intake Associated
    • 7.2.5. Digital Exposure
    • 7.2.6. Age-Related
  • 7.3. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 7.3.1. Aqueous Deficient
    • 7.3.2. Evaporative
  • 7.4. Latin America Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 7.4.1. Hospitals
    • 7.4.2. Eye Care Centers
    • 7.4.3. Ambulatory Surgical Centers
    • 7.4.4. Others
  • 7.5. Latin America Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
    • 7.5.1. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 7.5.2. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 7.5.3. Brazil Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 7.5.4. Brazil Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 7.5.5. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 7.5.6. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 7.5.7. Mexico Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 7.5.8. Mexico Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 7.5.9. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 7.5.10. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 7.5.11. Argentina Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 7.5.12. Argentina Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 7.5.13. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 7.5.14. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 7.5.15. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 7.5.16. Rest of LATAM Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
  • 7.6. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, 2019-2032

  • 8.1. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Type, Value (US$ Mn), 2019-2032
    • 8.1.1. Meibomian Gland Unclogging Devices
    • 8.1.2. Punctual Occlusion Devices
    • 8.1.3. Pain-Reliving Devices
    • 8.1.4. Others
  • 8.2. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, Value (US$ Mn), 2019-2032
    • 8.2.1. Idiopathic
    • 8.2.2. Rare Diseases
    • 8.2.3. Surgery
    • 8.2.4. Drug Intake Associated
    • 8.2.5. Digital Exposure
    • 8.2.6. Age-Related
  • 8.3. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, Value (US$ Mn), 2019-2032
    • 8.3.1. Aqueous Deficient
    • 8.3.2. Evaporative
  • 8.4. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by End Users, Value (US$ Mn), 2019-2032
    • 8.4.1. Hospitals
    • 8.4.2. Eye Care Centers
    • 8.4.3. Ambulatory Surgical Centers
    • 8.4.4. Others
  • 8.5. Middle East & Africa Dry Eye Disease Treatment Devices Market Outlook, by Country, Value (US$ Mn), 2019-2032
    • 8.5.1. GCC Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 8.5.2. GCC Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 8.5.3. GCC Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 8.5.4. GCC Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 8.5.5. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 8.5.6. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 8.5.7. South Africa Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 8.5.8. South Africa Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 8.5.9. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 8.5.10. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 8.5.11. Egypt Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 8.5.12. Egypt Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 8.5.13. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 8.5.14. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 8.5.15. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 8.5.16. Nigeria Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
    • 8.5.17. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Type, 2019-2032
    • 8.5.18. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Cause, 2019-2032
    • 8.5.19. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by Application, 2019-2032
    • 8.5.20. Rest of Middle East Dry Eye Disease Treatment Devices Market Outlook, by End Users, 2019-2032
  • 8.6. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

  • 9.1. Company Vs Segment Heatmap
  • 9.2. Company Market Share Analysis, 2024
  • 9.3. Competitive Dashboard
  • 9.4. Company Profiles
    • 9.4.1. Alcon Vision LLC
      • 9.4.1.1. Company Overview
      • 9.4.1.2. Product Portfolio
      • 9.4.1.3. Financial Overview
      • 9.4.1.4. Business Strategies and Developments
    • 9.4.2. Johnson and Johnson Services Inc
      • 9.4.2.1. Company Overview
      • 9.4.2.2. Product Portfolio
      • 9.4.2.3. Financial Overview
      • 9.4.2.4. Business Strategies and Developments
    • 9.4.3. AbbVie Inc.
      • 9.4.3.1. Company Overview
      • 9.4.3.2. Product Portfolio
      • 9.4.3.3. Financial Overview
      • 9.4.3.4. Business Strategies and Developments
    • 9.4.4. Lumenis Be Ltd
      • 9.4.4.1. Company Overview
      • 9.4.4.2. Product Portfolio
      • 9.4.4.3. Financial Overview
      • 9.4.4.4. Business Strategies and Developments
    • 9.4.5. ESW - Vision
      • 9.4.5.1. Company Overview
      • 9.4.5.2. Product Portfolio
      • 9.4.5.3. Financial Overview
      • 9.4.5.4. Business Strategies and Developments
    • 9.4.6. MiBo Medical Group
      • 9.4.6.1. Company Overview
      • 9.4.6.2. Product Portfolio
      • 9.4.6.3. Financial Overview
      • 9.4.6.4. Business Strategies and Developments
    • 9.4.7. Sight Sciences
      • 9.4.7.1. Company Overview
      • 9.4.7.2. Product Portfolio
      • 9.4.7.3. Financial Overview
      • 9.4.7.4. Business Strategies and Developments
    • 9.4.8. Eyedetec Medical Inc.
      • 9.4.8.1. Company Overview
      • 9.4.8.2. Product Portfolio
      • 9.4.8.3. Financial Overview
      • 9.4.8.4. Business Strategies and Developments
    • 9.4.9. BlephEx
      • 9.4.9.1. Company Overview
      • 9.4.9.2. Product Portfolio
      • 9.4.9.3. Financial Overview
      • 9.4.9.4. Business Strategies and Developments
    • 9.4.10. NuSight Medicals- NuLids LLC
      • 9.4.10.1. Company Overview
      • 9.4.10.2. Product Portfolio
      • 9.4.10.3. Financial Overview
      • 9.4.10.4. Business Strategies and Developments

10. Appendix

  • 10.1. Research Methodology
  • 10.2. Report Assumptions
  • 10.3. Acronyms and Abbreviations